Compound: 2-METHYLIMIDAZOLE
SMILES: n1c([nH]cc1)C
InChIKey: LXBGSDVWAMZHDD-UHFFFAOYSA-N
Synonyms: 2-METHYLIMIDAZOLE, 693-98-1, 2-Methyl-1H-imidazole, 1H-Imidazole, 2-methyl-, DTXSID4022107, T0049Z45LZ, CUREZOL-2MZ-P, IMICURE-AMI 2, EPICURE-MI 2, EPIKURE-MI 2, NSC-21394, DTXCID202107, RefChem:88340, 211-765-7, Imidazole, 2-methyl-, 2-Methylglyoxaline, 2-methyl imidazole, Ondansetron EP Impurity F, MFCD00005190, Ondansetron impurity F, CHEMBL293391, 2MZ, NCGC00091456-01, 2-methylimidazol, 2-Methyl-1H-imidazole; 1H-2-Methylimidazole; 2-Methylimidazole; 2MI; 2MZ; 2MZ-H, CAS-693-98-1, CCRIS 2459, EINECS 211-765-7, NSC 21394, methylimidazol, Methyl imidazol, UNII-T0049Z45LZ, 2methylimidazole, methyl-imidazole, AI3-50033, 2-metylimidazole, 2-Methylimdazole, HSDB 7756, 2-methyl-imidazol, 2-methyl-imidazole, 2-Methyl glyoxaline, 2-methyl-1h-imidazol, 2-Methylimidazole, 99%, SCHEMBL167, EC 211-765-7, Ondansetron impurity F CRS, SCHEMBL5294, METHYLIMIDAZOLE, 2-, WLN: T5M CNJ B1, SCHEMBL61745, MLS001065618, SCHEMBL155867, SCHEMBL194681, SCHEMBL443875, orb3026054, orb3027161, SCHEMBL1174216, SCHEMBL9901878, 2-METHYLIMIDAZOLE [HSDB], 2-METHYLIMIDAZOLE [IARC], HMS3039F06, NSC 21394-d5, NSC21394, STR02220, Tox21_111136, Tox21_201316, Tox21_302808, BBL013047, BDBM50295560, EBC-14487, SBB040944, STK301707, AKOS000118836, CS-W019983, FM11130, PB43299, MSK001052-1000M, NCGC00091456-02, NCGC00256531-01, NCGC00258868-01, PD063450, SMR000568464, 2-Methylimidazole (Ondansetron Impurity F), M0345, NS00010845, ST45053717, EN300-21278, C19261, D77862, F157400, 2-Methylimidazole Solution in Methanol, 1000ug/mL, BRD-K68534611-001-07-8, Q21099566, F2190-0640, Z104494990, InChI=1/C4H6N2/c1-4-5-2-3-6-4/h2-3H,1H3,(H,5,6, ONDANSETRON HYDROCHLORIDE DIHYDRATE IMPURITY F [EP IMPURITY], 2-Methylimidazole, >=95.0% (HPLC), pharmaceutical impurity standard, Ondansetron impurity F, European Pharmacopoeia (EP) Reference Standard, ONDANSETRON HYDROCHLORIDE IMPURITY, 2-METHYLIMIDAZOLE- [USP IMPURITY], 2-methylimidazole (GR 55299X),Ondansetron Hydrochloride Dihydrate Imp. F (EP), 2-Methyl-1H-imidazole, GR 55299X, Ondansetron Imp. F (EP), BP Ondansetron Impurity F, Ph Eur Ondansetron Impurity F, 2-Methylimidazole (Ondansetron Impurity F), Pharmaceutical Secondary Standard; Certified Reference Material, Ondansetron Hydrochloride Dihydrate Imp. F (EP), Ph Eur Ondansetron Impurity F, 2-methylimidazole (GR 55299X), Ondansetron Imp. F (EP), BP Ondansetron Impurity F, 2-Methyl-1H-imidazole, GR 55299X
Theoretical properties:
molecular_formula: C4H6N2
molecular_weight: 82.10 g/mol
exact_mass: 82.053098200 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 1
rotatable_bond_count: 0
heavy_atom_count: 6
topological_polar_surface_area: 28.7 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
physical_state: Solid
color: Solid
boiling_point: 267 °C
melting_point: 144 °C
solubility: Very soluble in ethanol
vapor_pressure: 0.01 [mmHg]
Descriptions:
pubchem: 2-Methylimidazole can cause cancer according to California Labor Code.
chembl: Unnamed Compound is a small molecule listed in the ChEMBL database but has not progressed to an approved clinical phase.
wikipedia: 2-Methylimidazole is an organic compound that is structurally related to imidazole with the chemical formula CH3C3H2N2H. It is a white or colorless solid that is highly soluble in polar organic solvents and water. It is a precursor to a range of drugs and is a ligand in coordination chemistry.